K Number
K093500
Device Name
POWDER FREE NITRILE EXAMINATION GLOVES, WHITE (NON-COLORED) OR BLUE (COLORED), NON-STERILE
Date Cleared
2010-01-19

(68 days)

Product Code
Regulation Number
880.6250
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
A powder free nitrile examination glove is a disposable device made of synthetic material intended to be worn on the hand for medical purposes to provide barrier against potentially infectious materials and other contaminants. In addition, this product is tested for use with chemotherapy drugs.
Device Description
Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored), Non Sterile (Chemotherapy Drug Protection Labeling Claim) will meet all the current specification for ASTM D6319.
More Information

Not Found

Not Found

No
The summary describes a standard examination glove and does not mention any AI or ML components or functionalities.

No.
The device is described as an examination glove intended to provide a barrier against infectious materials and contaminants, which is a protective rather than a therapeutic function.

No
The device is a nitrile examination glove intended as a barrier, not for diagnosing medical conditions.

No

The device is a physical glove, not software. The description clearly states it is a "powder free nitrile examination glove" and details its physical properties and testing against ASTM standards.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body to detect diseases or other conditions. They are used to diagnose, monitor, or screen for diseases.
  • Device Description and Intended Use: The description clearly states that this device is a "powder free nitrile examination glove" intended to be "worn on the hand for medical purposes to provide barrier against potentially infectious materials and other contaminants." It also mentions testing for use with chemotherapy drugs, which relates to its barrier function against these substances.
  • Lack of Biological Sample Testing: The device does not involve testing any biological samples taken from the body. Its function is a physical barrier.
  • Performance Metrics: The performance metrics listed are related to the physical properties of the glove (dimensions, pin-holes, powder residue, biocompatibility) and its ability to resist penetration by chemotherapy drugs (Breakthrough Detection Time). These are not metrics typically associated with diagnostic tests.

Therefore, based on the provided information, this device is a medical device used as a barrier, not an in vitro diagnostic.

N/A

Intended Use / Indications for Use

A powder free nitrile examination glove is a disposable device made of synthetic material intended to be worn on the hand for medical purposes to provide barrier against potentially infectious materials and other contaminants. In addition, this product is tested for use with chemotherapy drugs.

Product codes

LZC

Device Description

Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored), Non Sterile (Chemotherapy Drug Protection Labeling Claim) will meet all the current specification for ASTM D6319.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

hand

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The performance test data that support a determination of substantial equivalence are described above.
Clinical data are not needed for market cleared examination gloves.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 880.6250 Non-powdered patient examination glove.

(a)
Identification. A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls). The device, when it is a finger cot, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9.

0

K093500

V S Wear Safe (Malaysia) Sdn.Bhd. (Company No.204396-X)

FDA 510(k), Premarket Notification : 510(k) Summary of Safety and Effectiveness Information

1.0 Submitter:

WEAR SAFE (MALAYSIA) SDN. BHD. Lot PT 13726, Jalan Haji Salleh, Off Jalan Meru, 41050 Klang, Selangor Darul Eshan, Malaysia.

+603 3392 3088 Telephone No .: +603 3392 2118 Fax No .:

2.0 Contact Person:

Contact:Mr. SH TAN
E-mail:shtan@kossan.com.my
Telephone No.:+603 3291 2657
Fax No.:+603 3291 0584

3.0 Name of Device:

.

.

.

Trade Name:

Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored). Non-Sterile (Chemotherapy Drug Protection Labeling Claim) Patient Examination Glove Common Name: Classification Name: Patient Examination Glove.

Identification of The Legally Marketed Device: 4:0

The Powder Free Nitrile Examination Gloves, White (non colored) or Blue (colored), Non-Sterile (Chemotherapy Drug Protection Labeling Claim), Class I Patient Examination gloves, 80LZC. meets all of the requirements of ASTM D6319 Standard Specification for Nitrile Examination Gloves for Medical Application.

5.0 Description of Device:

Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored), Non Sterile (Chemotherapy Drug Protection Labeling Claim) will meet all the current specification for ASTM D6319.

Lot 13726, Jalan Haji Salleh, Batu 5% Off Jalan Meru, 41050 Klang, Selangor Darul Ehsan Malaysia. Tel: 603-33923088, Fax: 603-33922599

Page 1 of 3

1

K093500

Wear Safe (Malaysia) Sdn.Bhd. (Company No.204396-X)

6.0 Intended Use of the Device:

Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored), Non Sterile (Chemotherapy Drug Protection Labeling Claim) is a disposable device intended for medical purposes that is intended to be worn on the hand for medical purposes to provide barrier against potentially infectious materials and other contaminants. In addition, this product is tested for use with chemotherapy drugs.

7.0 Summary of The Technological Characteristics of The Device:

Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored), Non Sterile (Chemotherapy Drug Protection Labeling Claim) possesses the following technological characteristic (as compared to ASTM or equivalent standards):

CharacteristicStandardsDevice Performance
DimensionsASTM D6319 -
00a(2005)e1Meets
Physical PropertiesASTM D 412 - 06ae1Meets
Freedom from pin-holesASTM D 5151 - 06Meets
Powder Free ResidueASTM D 6124 - 06Meets
BiocompatibilityDermal Sensitization
(as per ASTM F720-81)

Primary Skin Irritation Test
(as per 16CFR Part1500) | Not a contact skin sensitizer

Not a primary skin irritant |

8.0 Substantial Equivalent Based on Assessment of Non-Clinical Performance Data

The performance test data that support a determination of substantial equivalence are described above.

9.0 Substantial Equivalent Based on Assessment of Clinical Performance Data

Clinical data are not needed for market cleared examination gloves.

Lot 13726, Jalan Haji Salleh, Batu 5% Off Jalan Meru, 41050 Klang, Selangor Darul Ehsan Malaysia. Tel: 603-33923088, Fax: 603-33922599

2

10.0 Conclusion

It can be concluded that the Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored) or, Non Sterile (Chemotherapy Drug Protection Labeling Claim) is safe and effective for use and will perform according to the glove performance standards referenced in Section 7 above, thereby meeting ASTM standards, FDA requirements, and the labeling claims for the product.

Consequently, this device is substantially equivalent to current marketed devices. This summary will include any other information reasonably deemed necessary by the FDA.

Lot 13726, Jalan Haji Salleh, Batu 5¼ Off Jalan Meru, 41050 Klang, Selangor Darul Ehsan Malaysia. Tel: 603-33923088, Fax: 603-33922599

Page 3 of 3

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized image of a human figure with outstretched arms, representing the department's mission to protect the health of all Americans.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-066-0609 Silver Spring, MD 20993-0002

JAN 1 9 2010

Mr. S.H. Tan Regulatory Affairs Department Manager Wear Safe MALAYSIA Sdn. Bhd. Lot PT 13726, Jalan Haji Salleh off Jalan Meru Klang Selangor Darul Ehsan MALAYSIA 41050

Re: K093500

Trade/Device Name: Powder Free Nitrile Examination Gloves, White (non-colored) or Bule (colored), Non-Sterile (Chemotherapy Drug Protection Labeling Claim) Regulation Number: 21CFR 880.6250 Regulation Name: Patient Examination Glove Regulatory Class: I Product Code: LZC Dated: December 23, 2009 Received: December 29, 2009

Dear Mr. Tan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device. Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties: We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

4

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to

http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely vours.

Susan Gunner

Anthony D. Watson, BS, MS, MBA Director

Division of Anesthesiology, General Hospital, Infection Control. and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

K093500

Wear Safe (Malaysia) Sdn.Blid. (Company No.204396-X)

revised copy

INDICATIONS FOR USE

Applicant: WEAR SAFE (MALAYSIA) SDN. BHD.

510(k) Number (if known): K093500

Device Name: Powder Free Nitrile Examination Gloves, White (non-colored) or Blue (colored), Non-Sterile (Chemotherapy Drug Protection Labeling Claim)

Indication For Use: A powder free nitrile examination glove is a disposable device made of synthetic material intended to be worn on the hand for medical purposes to provide barrier against potentially infectious materials and other contaminants. In addition, this product is tested for use with chemotherapy drugs.

Powder Free Nitrile Patient Examination Gloves, White (Non-Colored) Non Sterile (Chemotherapy Drugs
Protection Claim):
Chemotherapy Drug Permeation (Breakthrough Detection Time) in Minutes
The following chemotherapy drugs have been tested:
Carmustine (BCNU) (3.3mg/ml)71.3
Cisplatin (1.0 mg/ml)>240
Cyclophosphamide (Cytoxan) (20.0 mg/ml)>240
Dacarbazine (DTIC) (10.0 mg/ml)>240
Doxorubicin Hydrochloride (2.0 mg/ml)>240
5-Fluorouracil (50.0 mg/ml)>240
Etoposide (Toposar) (20.0 mg/ml)>240
Paclitaxel (Taxol) (6.0 mg/ml)>240
ThioTepa (10.0 mg/ml)72.36

Powder Free Nitrile Patient Examination Gloves, Blue (Colored) Non sterile (Chemotherapy Drugs Protection Claim):

Chemotherapy Drug Permeation (Breakthrough Detection Time) in Minutes The following chemotherapy drugs have been tested:

The following chemotherapy drugs have been tested.
Carmustine (BCNU) (3.3mg/ml)60.7
Cisplatin (1.0 mg/ml)>240
Cyclophosphamide (Cytoxan) (20.0 mg/ml)>240
Dacarbazine (DTIC) (10.0 mg/ml)>240
Doxorubicin Hydrochloride (2.0 mg/ml)>240
5-Fluorouracil (50.0 mg/ml)>240
Etoposide (Toposar) (20.0 mg/ml)>240
Paclitaxel (Taxol) (6.0 mg/ml)>240
ThioTepa (10.0 mg/ml)69.0

. Lot 13726, Jalan Haji Salleh, Batu 5% Off Jalan Meru, 41050 Klang, Selangor Darul Ehsan Malaysia. Tel: 603-33923088, Fax: 603-33922599

6

KD93500

WSM Wear Safe (Malaysia) Sdn.Bhd. (Company No.204396-X)

revised copy

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use X AND/OR (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Elizabeth P. Clavier Will

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Number. K093500

Page 2 of 2

Lot 13726, Jalan Haji Salleh, Batu 5% Off Jalan Meru, 41050 Klang, Selangor Darul Ebsan Malaysia. Tel: 603-33923088, Fax: 603-33922599